• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由 SARS-CoV-2 引起的中枢神经系统损伤的表现和机制。

Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.

机构信息

Department of Anesthesiology, Shengjing Hospital of China Medical University, Sanhao Street 36, Shenyang 110004, China.

Clinical Skills Center, Shenyang Medical College, Huanghe Street 146, Shenyang 110034, China.

出版信息

Brain Res Bull. 2021 Dec;177:155-163. doi: 10.1016/j.brainresbull.2021.09.015. Epub 2021 Sep 24.

DOI:10.1016/j.brainresbull.2021.09.015
PMID:34571039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8462004/
Abstract

The global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its threat to humans have drawn worldwide attention. The acute and long-term effects of SARS-CoV-2 on the nervous system pose major public health challenges. Patients with SARS-CoV-2 present diverse symptoms of the central nervous system. Exploring the mechanism of coronavirus damage to the nervous system is essential for reducing the long-term neurological complications of COVID-19. Despite rapid progress in characterizing SARS-CoV-2, the long-term effects of COVID-19 on the brain remain unclear. The possible mechanisms of SARS-CoV-2 injury to the central nervous system include: 1) direct injury of nerve cells, 2) activation of the immune system and inflammatory cytokines caused by systemic infection, 3) a high affinity of the SARS-CoV-2 spike glycoprotein for the angiotensin-converting enzyme ACE2, 4) cerebrovascular disease caused by hypoxia and coagulation dysfunction, and 5) a systemic inflammatory response that promotes cognitive impairment and neurodegenerative diseases. Although we do not fully understand the mechanism by which SARS-CoV-2 causes nerve injury, we hope to provide a framework by reviewing the clinical manifestations, complications, and possible mechanisms of neurological damage caused by SARS-CoV-2. With hope, this will facilitate the early identification, diagnosis, and treatment of possible neurological sequelae, which could contribute toward improving patient prognosis and preventing transmission.

摘要

由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的全球大流行及其对人类的威胁引起了全球关注。SARS-CoV-2 对神经系统的急性和长期影响带来了重大的公共卫生挑战。SARS-CoV-2 感染者表现出中枢神经系统的各种症状。探索冠状病毒对神经系统的损伤机制对于减少 COVID-19 的长期神经系统并发症至关重要。尽管在描述 SARS-CoV-2 方面取得了快速进展,但 COVID-19 对大脑的长期影响仍不清楚。SARS-CoV-2 损伤中枢神经系统的可能机制包括:1)直接损伤神经细胞,2)全身感染引起的免疫系统和炎症细胞因子激活,3)SARS-CoV-2 刺突糖蛋白与血管紧张素转换酶 ACE2 的高亲和力,4)缺氧和凝血功能障碍引起的脑血管病,以及 5)全身性炎症反应促进认知障碍和神经退行性疾病。虽然我们不完全了解 SARS-CoV-2 引起神经损伤的机制,但我们希望通过回顾 SARS-CoV-2 引起的神经系统损伤的临床表现、并发症和可能的机制,提供一个框架。希望这将有助于早期识别、诊断和治疗可能的神经系统后遗症,从而改善患者预后并防止传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/9b5b79d664b2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/e7798293fb1b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/1c130ea58ca1/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/9b5b79d664b2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/e7798293fb1b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/1c130ea58ca1/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529b/8462004/9b5b79d664b2/gr3_lrg.jpg

相似文献

1
Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.由 SARS-CoV-2 引起的中枢神经系统损伤的表现和机制。
Brain Res Bull. 2021 Dec;177:155-163. doi: 10.1016/j.brainresbull.2021.09.015. Epub 2021 Sep 24.
2
Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.新型冠状病毒(COVID-19)靶向中枢神经系统的可能机制及神经症状:文献复习。
Eur Rev Med Pharmacol Sci. 2023 Oct;27(19):9420-9428. doi: 10.26355/eurrev_202310_33970.
3
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.SARS-CoV-2 引发的神经系统表现:复杂性、机制与相关紊乱。
Eur J Med Res. 2023 Aug 30;28(1):307. doi: 10.1186/s40001-023-01293-2.
4
Neurological manifestations and comorbidity associated with COVID-19: an overview.与 COVID-19 相关的神经系统表现和共病:概述。
Neurol Sci. 2020 Dec;41(12):3409-3418. doi: 10.1007/s10072-020-04823-6. Epub 2020 Oct 14.
5
SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.SARS-CoV-2 感染与中枢及外周神经系统相关的并发症及其潜在发病机制。
Mol Neurobiol. 2021 Jun;58(6):2465-2480. doi: 10.1007/s12035-020-02245-1. Epub 2021 Jan 13.
6
Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.新型冠状病毒感染引发的炎症反应导致血脑屏障损伤相关的神经并发症。
Mol Neurobiol. 2021 Feb;58(2):520-535. doi: 10.1007/s12035-020-02134-7. Epub 2020 Sep 25.
7
Neurological manifestations and pathogenic mechanisms of COVID-19.新型冠状病毒肺炎的神经表现和发病机制。
Neurol Res. 2022 Jul;44(7):571-582. doi: 10.1080/01616412.2021.2024732. Epub 2022 Jan 6.
8
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.COVID-19 急性和慢性神经与神经精神后遗症的医学视角。
Curr Neuropharmacol. 2022;20(6):1229-1240. doi: 10.2174/1570159X20666211223130228.
9
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.全面综述 COVID-19 的生物学、诊断学、治疗学,以及对中枢神经系统产生影响的疾病。
J Neurovirol. 2021 Oct;27(5):667-690. doi: 10.1007/s13365-021-00998-6. Epub 2021 Sep 28.
10
Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.新型冠状病毒2019感染与神经系统疾病之间的相互作用:综述
CNS Neurol Disord Drug Targets. 2023;22(5):643-658. doi: 10.2174/1871527321666220418114009.

引用本文的文献

1
Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation.血脑屏障处的天然免疫传感器与调节因子:聚焦于作为神经免疫串扰和炎症介质的Toll样受体和炎性小体。
J Neuroinflammation. 2025 Feb 15;22(1):39. doi: 10.1186/s12974-025-03360-3.
2
Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care.新冠后综合征相关认知障碍的管理:基层医疗建议
Front Pharmacol. 2024 Apr 22;15:1338235. doi: 10.3389/fphar.2024.1338235. eCollection 2024.
3
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

本文引用的文献

1
Long covid-mechanisms, risk factors, and management.长新冠的发病机制、危险因素和管理。
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.
2
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.利用 ISARIC WHO 临床特征协议 UK 对 COVID-19 相关院内并发症进行特征描述:一项前瞻性、多中心队列研究。
Lancet. 2021 Jul 17;398(10296):223-237. doi: 10.1016/S0140-6736(21)00799-6.
3
Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
阿尔茨海默病患者大脑中的血管紧张素转换酶 2(ACE2)水平更高。
Acta Neuropathol Commun. 2023 Oct 2;11(1):159. doi: 10.1186/s40478-023-01647-1.
4
Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.阿尔茨海默病患者大脑中血管紧张素I转换酶2(ACE2)水平较高。
bioRxiv. 2023 Jan 18:2023.01.17.524254. doi: 10.1101/2023.01.17.524254.
5
Just When We Thought That COVID Was Over: A Systematic Review.正当我们以为新冠疫情已经结束时:一项系统综述。
Cureus. 2022 Jul 29;14(7):e27441. doi: 10.7759/cureus.27441. eCollection 2022 Jul.
6
Editorial: Viral infection and brain diseases.社论:病毒感染与脑部疾病
Brain Res Bull. 2022 Oct 1;188:108-109. doi: 10.1016/j.brainresbull.2022.07.012. Epub 2022 Jul 21.
随机临床试验“COVID-19 后的嗅觉功能障碍:棕榈酸乙醇酰胺和芦丁嗅觉康复治疗与干预治疗的比较”:初步结果。
Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4156-4162. doi: 10.26355/eurrev_202106_26059.
4
Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study.COVID-19 住院后后遗症、持续症状和结局:ANCOHVID 多中心 6 个月随访研究。
BMC Med. 2021 May 20;19(1):129. doi: 10.1186/s12916-021-02003-7.
5
Central Nervous System Manifestations of COVID-19: A Critical Review and Proposed Research Agenda.COVID-19 相关的中枢神经系统表现:批判性综述与研究议程建议。
J Int Neuropsychol Soc. 2022 Mar;28(3):311-325. doi: 10.1017/S1355617721000345. Epub 2021 Apr 16.
6
Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables.新冠出院四个月后认知障碍:模式、严重程度与疾病变量的关联。
Eur Neuropsychopharmacol. 2021 May;46:39-48. doi: 10.1016/j.euroneuro.2021.03.019. Epub 2021 Mar 29.
7
Neuropsychiatric and Cognitive Sequelae of COVID-19.新型冠状病毒肺炎的神经精神和认知后遗症
Front Psychol. 2021 Mar 2;12:577529. doi: 10.3389/fpsyg.2021.577529. eCollection 2021.
8
Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months.欧洲首例 2019 冠状病毒病疫情中的嗅觉丧失:8 个月后的功能恢复。
J Laryngol Otol. 2021 Mar;135(3):224-228. doi: 10.1017/S0022215121000670. Epub 2021 Feb 26.
9
Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations.从 COVID-19 中康复且无神经系统表现的患者的长期微观结构和脑血流变化。
J Clin Invest. 2021 Apr 15;131(8). doi: 10.1172/JCI147329.
10
Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.阿尔茨海默病患者大脑中血管紧张素转换酶 2(ACE2)的蛋白表达上调。
Int J Mol Sci. 2021 Feb 8;22(4):1687. doi: 10.3390/ijms22041687.